Endometriosis
Myoma
Oncology
Cerrvix pathology
Endocrinology
Endoscopic surgery
Infertility
29
Scopus Publications
206
Scholar Citations
6
Scholar h-index
3
Scholar i10-index
Scopus Publications
FEATURES OF ASSESSING THE CONDITION OF PREGNANT WOMEN WITH PARATHYROID ADENOMA В.П. Міщенко, І.З. Гладчук, V.V. Mishchenko Reproductive Endocrinology, 2026 The relevance of this topic lies in the lack of reliable statistical data in available literature regarding the incidence of parathyroid gland disorders in pregnant women and the differences in diagnosis and therapy during pregnancy versus outside of pregnancy. A physician’s knowledge of the physiological changes that occur in a woman’s body during pregnancy, including mineral metabolism and endocrine gland function, facilitates accurate and timely differential diagnosis between parathyroid tumors, physiological processes, and symptoms of gestational complications. Differential diagnosis of parathyroid pathology from gestational processes at various stages of pregnancy is complex. Timely detection of parathyroid pathology is particularly important at the stage of pregnancy planning. Differential diagnosis of parathyroid adenoma is carried out in comparison with gestational processes, including gestational complications such as nausea and vomiting in pregnant women. Late diagnosis of clinical manifestations of parathyroid pathology in pregnancy can lead to severe consequences for both the mother and the fetus. For this reason, in clinical practice, timely detection of parathyroid pathology during the pregnancy planning stage is essential. Examination of pregnant women and determination of therapeutic interventions should be multidisciplinary, personalized, and include measurement of blood levels of thyroid-stimulating hormone, vitamin D, calcium, magnesium, phosphorus, and parathyroid hormone. Therapeutic options for hyperparathyroidism in pregnant women are limited. A personalized and multidisciplinary approach is essential in each individual case. Women with parathyroid tumors require individualized, qualified monitoring during both the early and late postpartum periods and during lactation, as there is always a risk of hypercalcemia. Administration of vitamin D should be carried out under laboratory control of its blood levels in pregnant women and should be personalized, taking into account the gestational age. In newborns of mothers with parathyroid tumors, it is necessary to monitor calcium levels in both blood and urine.
The symptom-modifying effect of dienogest in patients with genital endometriosis who have proliferative changes in the mammary glands A.S. Lunko, A.G. Volyanska, I.Z. Gladchuk Reproductive Health of Woman, 2026 Modern studies show that in different countries 15–70% of patients with genital endometriosis (GE) have concomitant breast pathology, which is considered a manifestation of overlap syndrome. This category of patients requires a detailed examination of the mammary glands when choosing hormonal therapy, as well as more careful observation during treatment.The objective: to assess the symptom-modifying effect of dienogest in patients with GE who have proliferative changes in the mammary glands.Materials and methods. 226 women of reproductive age with GE were examined. Staging of endometriosis was performed according to the revised version of the American Society of Reproductive Medicine classification after laparoscopic intervention. Diagnosis, treatment and clinical monitoring of patients were carried out in compliance with modern bioethical requirements, as well as in accordance with the recommendations of the World Health Organization and the American College of Obstetricians and Gynecologists. All patients had ultrasound examination of the mammary glands. Changes in functional status were assessed using the Breast imaging reporting and data system (BI-RADS) scale. Endopain questionnaire was used to determine the intensity of pain syndrome in GE. As a symptom-modifying drug, patients were prescribed dienogest 2 mg once a day for 24 weeks. The presence of clinical manifestations of GE was determined before and after treatment.Results. Proliferative changes in the tissues of the mammary gland were detected in 65.6% of the examined patients with GE. As the stage of endometriosis progresses, the severity of proliferative changes in the mammary glands increases (positive correlation of medium strength with the stage of external GE was found, r = 0.53; p < 0.05). In the selected cohort of patients, the use of dienogest 2 mg for 6 months led to a decrease in the intensity, and in many cases to the disappearance of chronic pelvic pain syndrome and other manifestations of the disease: algodysmenorrhea and dyspareunia.Conclusions. The study confirmed the world data that the overlap syndrome of GE and dyshormonal breast diseases is a common clinical phenomenon. It has been established that with increasing stage of endometriosis, there is an increase in the breast pathologies frequency. In the treatment of patients with overlap syndrome of GE and dyshormonal breast diseases, the effectiveness of dienogest has been confirmed, as evidenced by the regression of clinical symptoms of GE, in particular, a decrease in the intensity of chronic pelvic pain syndrome. It is important that hormonal therapy for endometriosis has demonstrated a high safety profile, because it not only does not provoke the occurrence of side effects, but also does not have an undesirable effect on the functional state of the mammary glands.
Impact of lesion size and localization on symptom severity in intestinal endometriosis Yuliia Ocheretna, Natalia Rozhkovska, Vitaliy Kozhakov, Vasyl Gladchuk, Hanna Shytova, Yurii Petrovskiy, Igor Gladchuk, Harald Krentel Frontiers in Medicine, 2026 Background/objectives Intestinal endometriosis (IE) often presents with dyschezia, gastrointestinal (GI) dysfunction, dyspareunia, and dysmenorrhea. The impact of lesion localization and size on the severity of symptoms remains insufficiently studied, complicating preoperative diagnosis, treatment planning, and surgical excision. The aim is to assess preoperative symptoms in women with intestinal endometriosis and to evaluate the impact of lesion localization and size according to the #Enzian classification on the severity of pain and GI symptoms. Methods A retrospective analysis of medical records was conducted for 135 patients with laparoscopically confirmed intestinal endometriosis (IE) at the Multidisciplinary Medical Center of Odesa National Medical University. Lesion localization and size were classified intraoperatively according to the #Enzian classification in a surgically treated cohort of women. The presence and severity of pain (dysmenorrhea, dyspareunia, dyschezia) and gastrointestinal symptoms (constipation, diarrhea, abdominal pain, bloating, nausea, fecal incontinence, hematochezia) were analyzed. Results Pain and/or gastrointestinal symptoms were present in 121 patients (89.6%), while 14 patients (10.4%) did not report such symptoms. Large rectal nodules (#Enzian C3) were associated with higher severity of dyschezia, hematochezia, and abdominal pain compared with smaller lesions (#Enzian C1–C2) ( p &lt; 0.001). Hematochezia was observed only in patients with #Enzian compartment C (C2, C3) involvement. Patients with additional bowel lesions (#Enzian FI) were associated with a higher risk of bloating compared with rectal lesions alone. Combined lesions (#Enzian C and FI) are also associated with more severe hematochezia compared with #Enzian C/#Enzian FI alone ( p = 0.002) and dyschezia compared with #Enzian FI alone ( p = 0.03). #Enzian FI lesion size did not influence these results significantly but the analysis was likely underpowered for FI size effects. Conclusion Large rectal lesions (#Enzian C3) are associated with more severe dyschezia, abdominal pain, and hematochezia. The presence of additional intestinal lesions (#Enzian FI) is associated with increased severity of hematochezia and the risk of bloating.
AN UNUSUAL CASE OF PRIMARY FALLOPIAN TUBE CANCER N. М. Rozhkovska, Дмитрий Георгиевич Сумцов, Georgyi Sumtsov, S.A. Smiian, Tetiana O. Savenko, et al. Eastern Ukrainian Medical Journal, 2025 Introduction. Cases with an open ampullary opening among primary fallopian tube cancer (PFTC) are extremely rare, highly malignant, and difficult to diagnose. Primary fallopian tube cancer accounts for 1.8% of female genital cancers and about 4-6% of cancers of the uterine appendages. According to available data, the incidence of this tumour has increased up to 4 times in recent decades. Preoperative diagnosis of the PFTC has been and remains an unresolved problem for cervical cancer, which leads to untimely treatment or treatment in non-oncological institutions. Even during surgeries, errors reach 50%, which provokes inadequate surgeries and treatment methods and delays the recovery of patients. Objective: to demonstrate a case of misdiagnosis during surgery, the need for oncological care and a detailed study of the macro preparation in the operating room. Material and Methods: the results of clinical, morphological and immunohistochemical examination of the case of primary fallopian tube tract and analysis of publications in the relevant literature. Results and Discussion: The clinical, morphological and immunohistochemical analysis of an unusual case of primary fallopian tube cancer was performed. The diagnosis was made only after a routine histological and immunohistochemical examination. A broader review of this clinical case will improve cancer screening and diagnosis. Primary fallopian tube cancer remains a rare but challenging problem in terms of diagnosis and treatment. Improving diagnostic accuracy is based on a thorough preoperative examination of patients with any pathological changes in the uterine appendages, including the study of tumour markers of epithelial tumours (CA-125, НE-4, etc.). In recent years, the prevention of cancer of the fallopian tubes, ovaries, pelvic peritoneum and mammary glands by opportunistic salpingectomy has been actively implemented, with cases of primary and metastatic tumours in the fallopian tubes being reported. There have been some reports of malignant tumours developing after ‘preventive’ surgeries, although the cause of such outcomes is unknown, and the question of whether they can be avoided remains open. Conclusion: Only cancer awareness and careful examination of the removed material in the operating room and the use of suboperative morphological diagnostics will allow avoiding such errors during surgery. Abnormal uterine bleeding cannot be the result of a tumour microsite.
Effectiveness of laparoscopic correction of niche after cesarean section I.Z. Gladchuk, N.M. Rozhkovska, Z.I. Gladchuk Reproductive Health of Woman, 2025 The frequency of niche after cesarean section (NACS) is 25–85% and depends on many factors, increasing with each next cesarean section, which can cause chronic abnormal uterine bleeding, pelvic pain, subfertility.The objective: to evaluate the immediate and long-term results of the developed method of laparoscopic correction of symptomatic NACS.Materials and methods. During 2022–2024, 58 patients of reproductive age were prospectively observed in the clinics of the Odesa National Medical University: 28 women (main group) with a NACS and 30 practically healthy women of the same age with a uterine scar who were examined for male factor infertility (control group). A comprehensive assessment of the uterine scar, length, depth, width of the niche, and thickness of the residual myometrium was performed using ultrasound examonation. The histological structure of the endometrium and myometrium was studied. All patients in the main group underwent laparoscopic isthmoplasty using the developed technique (two-row separate Vicryl (2.0) sutures with delayed tying of 1 row of sutures).Results. The niche was visualized by transvaginal ultrasound examination as a defect in the myometrium in the anterior uterine wall of a triangular, oval or irregular shape, with a depth of 6.3 ± 1.6 mm, the thickness of the residual myometrium was from 2 to 4 mm, on average 3.0 ± 0.3 mm. The most frequent symptoms of the NACS were menorrhagia – 35.7%, intermenstrual bleeding – 32.1%, perimenstrual spotting – 67.9%, chronic pelvic pain – 57.1%, dysmenorrhea – 64.3%, dyspareunia – 53.6%, chronic vaginal discharge – 28.6% and subfertility – 53.6% of cases. Laparoscopic isthmoplasty according to the developed technique after 3 months after surgery contributed to a significant reduction in the frequency of menorrhagia by 3.3 times (p < 0.01), intermenstrual bleeding by 3.0 times (p < 0.01), perimenstrual spotting by 3.2 times (p < 0.01), as well as chronic pelvic pain by 2.7 times (p < 0.01), dysmenorrhea by 2.2 times (p < 0.05), dyspareunia by 2.5 times (p < 0.05), chronic vaginal discharge with a stable clinical effect 6 and 12 months after surgery. The thickness of the residual myometrium after laparoscopic isthmoplasty increased from 3.0 ± 0.6 to 4.5 ± 0.4 mm after 3 months, to 5.2 ± 0.6 mm after 6 months and up to 5.9 ± 0.5 mm 12 months after laparoscopic treatment (p < 0.01).Conclusions. Laparoscopic correction of symptomatic NACS using the developed technique helps to reduce symptoms of abnormal uterine bleeding, pelvic pain, increase the thickness of the residual myometrium, and improves the pregnancy rate in patients with subfertility.
COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF LAPAROSCOPIC ORGAN-PRESERVING TREATMENT OF DEEP ENDOMETRIOSIS USING THE STANDARDIZED METHOD AND THE TRADITIONAL METHOD Kh. D. Haidarzhi, G. L. Lavrynenko, I. Z. Gladchuk Odesa Medical Journal, 2025 Deep endometriosis is the most aggressive type of endometriosis with deep tissue infiltration, leading to disruption of the anatomy and functionality of vital organs and a decrease in the quality of life.The aim of the study. To conduct a comparative analysis of intraoperative and postoperative indicators of organ-preserving surgical treatment of women with deep endometriosis accompanied by pain syndrome, using a standardized technique and a traditional laparoscopic method.Materials and methods. A comparative study was conducted, involving 309 patients of reproductive age with pain syndrome, who underwent surgery for deep endometriosis. The main group (I clinical) consisted of 210 patients who were operated on using the standardized method proposed by us. The comparison group (II clinical) consisted of 99 patients who were operated on using the traditional laparoscopic method.Results. Improvement of intraoperative parameters was obtained in the main group, in particular, a reduction in the duration of the operation (122.32 ± 2.61 min in the main group and 148.44 ± 3.05 min in the control group, p < 0.001), reduction in blood loss (136.13 ± 2.41 ml in the main group and 174.43 ± 3.23 ml in the control group, p < 0.001); early postoperative indicators, namely, a decrease in the duration of hospital stay (in the main group 4.17 ± 0.1 days and in the control group 5.42 ± 0.16 days, p < 0.001); reduction of Clavien-Dindo class I complications (cases of postoperative intestinal paresis decreased by 4.9 times, the number of cases of urination dysfunction – by 4.2 times). In both group, no difference was found in Clavien-Dindo class II, III and IV complications. A significant reduction in pain scores was obtained 6 month after surgery in both groups, with no significant difference between the groups.Conclusions. The use of a standardized surgical intervention algorithm helps improve some intraoperative and early postoperative indicators of surgical treatment of deep endometriosis.
The effectiveness of iron deficiency nutritional correction in patients with genital endometriosis accompanied by mild anemia I.Z. Gladchuk, A.G. Volyanska, A.S. Lunko, T.A. Lunko Emergency Medicine Ukraine, 2025 Background. Women with endometriosis are at higher risk of developing iron deficiency than those without endometriosis. The results of many studies indicate that iron deficiency should be considered during the initial diagnosis and subsequent treatment of endometriosis, since menstrual disorders with the simultaneous presence of endometrioid heterotopias are one of the factors for the development of anemia in women. The purpose was to study the effectiveness of nutritional correction of iron deficiency in patients with genital endometriosis accompanied by dysmenorrhea. Materials and methods. Endometriosis patients with mild anemia were prescribed nutritional correction of iron deficiency. In the study group (n = 34), women received a complex of microencapsulated iron pyrophosphate (14 mg) in liposomal form with folic acid (200 μg), vitamin B12 (2.5 μg) and vitamin C (80 mg), as well as a dietary supplement of lactoferrin at a dose of 250 mg per day for 2 months; in the comparison group (n = 32), the above-mentioned combination drug was administered without adding lactoferrin to the diet. The patients were assessed for the following indicators: hemoglobin level, erythrocyte count, ferritin levels, transferrin and total serum iron concentration before treatment and after 2 months. Results. Nutritional correction of iron deficiency in patients with endometriosis accompanied by mild anemia with the use of a complex of iron pyrophosphate and vitamins is not only effective, but also safe, because no side effects of diet therapy were recorded. Adding the dietary supplement lactoferrin to the iron-vitamin preparation improves restoration of the iron metabolism level and normalizes its key indicators: hemoglobin, ferritin and serum iron, and leads to a more significant increase in transferrin. It is also important that the mean corpuscular hemoglobin concentration in the study group reached normal, while in the comparison group, it only approached normal values. Conclusions. Lactoferrin in combination with an iron-vitamin complex can provide the most favorable conditions for the absorption of the required amount of iron against the background of a decrease in the inflammation and normalization of the microbiota. Due to its affinity for transferrin, lactoferrin participates in the full restoration of the proper level of iron metabolism, which is consistent with the data of other studies in recent years.
Endometrial stromal sarcoma: description of a rare clinical case I.Z. Gladchuk, N.M. Rozhkovska, O.S. Saleh, T.O. Savenko Reproductive Health of Woman, 2025 The rapid growth of uterine leiomyoma and disruption of its nutrition require differentiation from uterine sarcoma, although the incidence of sarcoma is about 1% of all malignant gynecological diseases. After myomectomy or hysterectomy, there is a 0.2–0.5% risk of detecting endometrial stromal sarcoma, and the differential diagnosis of cellular leiomyoma and sarcoma is difficult not only for clinicians but also for pathologists. Given the rarity and complexity of diagnosing endometrial stromal sarcoma, each case is of significant clinical and scientific interest.The article presents a clinical case of endometrial stromal sarcoma in a teenage girl. A 16-year-old female patient consulted her family doctor complaining of a fever of 38–39 °C for several days and general weakness. The examination revealed no changes in the lungs. She had regularly menses since the age of 12, but for the last 3 months her periods had been heavier and longer, leading to moderate anemia. An ultrasound examination, magnetic resonance imaging, and diagnostic laparoscopy at a children’s hospital led to a diagnosis of uterine fibroids. Due to suspected necrosis of the myomatous node, Pfannenstiel laparotomy and conservative myomectomy were performed. In the postoperative period, fever persisted, there was the resistance to anti-inflammatory and antibacterial therapy, as well as leukocytosis and lymphopenia, accompanied by increased levels of inflammation markers and the formation of hematoma and infiltrate in the abdominal cavity. The histological result indicate the low-grade endometrial stromal sarcoma; the material was sent for review and immunohistochemical (IHC) examination, which diagnosed high-grade endometrial stromal sarcoma.Given the histological diagnosis of sarcoma and the development of inflammatory complications, a decision was made to perform a hysterectomy with appendages, a biopsy of the greater omentum, and to change the antibiotic therapy in accordance with the sensitivity of the detected microorganism (Enterococcus faecium). Histological and IHC examinations of the removed uterus with appendages confirmed the presence of low-grade endometrial stromal sarcoma, positive for estrogen and progesterone receptors, with wild-type p53 expression and the presence of inflammatory changes. Positive clinical dynamics were observed in the postoperative period. The patient was discharged in satisfactory condition and referred to the National Cancer Institute of Ministry of Health of Ukraine, where she was consulted by a multidisciplinary team of specialists and diagnosed with low-grade endometrial stromal sarcoma T1N0M0 stage 1, clinical group 2. Megestrol acetate at a dose of 160 mg was prescribed as adjuvant therapy for 2 years. Follow-up computed tomography of the chest, abdomen, and pelvis 3 and 6 months after surgery showed no signs of disease progression.Conclusions. Endometrial stromal sarcoma is a rare malignant uterine tumor that can mimic the clinical picture of leiomyoma, especially in young patients. Differential diagnosis between cellular leiomyoma and uterine sarcoma is difficult even for experienced morphologists, which necessitates the use of IHC methods. The presence of rapid tumor growth and signs of impaired nutrition requires cancer awareness and careful preoperative examination. A multidisciplinary approach of surgical treatment, pathomorphological confirmation, and adjuvant hormonal therapy contributes to the achievement of favorable short-term results.
COMPARATIVE ANALYSIS OF THE FREQUENCY OF POSTOPERATIVE INTRAUTERINE ADHESIONS WITH CLASSICAL AND MODIFIED HYSTEROSCOPIC METROPLASTY Yu. L. Kalitsynska, И. З. Гладчук, D. O. Hryhurko Reproductive Endocrinology, 2024 Background. Treatment of women with RPL-syndrome (recurrent pregnancy loss), which is caused by intrauterine septum, involves hysteroscopic metroplasty. However, the main drawback of these methods is the risk of formation of the intrauterine adhesions in 35–50% of patients in the postoperative period. Modern methods of preventing the formation of postoperative intrauterine adhesions are not always effective.Objectives. To conduct a comparative analysis of the postoperative intrauterine adhesions frequency after proposed and traditional electrosurgical hysteroscopic metroplasty. Materials and methods. 138 patients with primary miscarriage (RPL-syndrome) and/or premature birth who had intrauterine septum and were operated on between 2016 and 2021 participated in the study. The main group consisted of 88 patients aged 27.52 ± 1.59 years who were performed hysteroscopic metroplasty according to the proposed modified technique. The comparative group consisted of 50 patients at the age of 28.21 ± 1.65 years that get surgical treatment according to the classical method of hysteroscopic metroplasty. The effectiveness of operations was evaluated using the «Menstrual blood loss assessment» scale (order of the Ministry of Health of Ukraine No. 353 dated 04/13/2016), the 2D/3D ultrasound method, and second-look hysteroscopy data.Results. In the main group, unlike the comparison group, postoperative hypomenorrhea was 3 times less frequent and ultrasound signs of adhesions were 2.2 times less frequent; intrauterine adhesions were detected 25% less often according to second-look hysteroscopy (p < 0.05).Conclusions. The modified technique of hysteroscopic metroplasty in comparison with the traditional technique of surgery in women with RPL-syndrome helps to reduce the frequency of postoperative intrauterine adhesions by 25%. The obtained results are preliminary and require further research.
Особливості оцінки стану вагітних з аденомою прищитоподібних залоз ВП Міщенко, ІЗ Гладчук, ВВ Міщенко Інститут педіатрії, акушерства і гінекології імені академіка ОМ Лук'янової … , 2026 2026
Роль фізикального обстеження, трансвагінальної ультрасонографії та магнітно-резонансної томографії у діагностиці ендометріозу кишечника ЮС Очеретна, ІЗ Гладчук УкрНДІ МТ МОЗ України , 2026 2026
Симптомо-модифікувальна дія дієногесту у хворих із генітальним ендометріозом та проліферативними змінами молочних залоз АС Лунько, АГ Волянська, ІЗ Гладчук ТОВ «Професіонал-Івент», Таллінн , 2026 2026
Саркома ендометріальної строми: опис рідкісного клінічного випадку ІЗ Гладчук, НМ Рожковська, ОС Салех, ТО Савенко Репродуктивне здоров'я жінки, 160-168 , 2025 2025
Ефективність лапароскопічної корекції ніші після кесаревого розтину ІЗ Гладчук, НМ Рожковська, ЗІ Гладчук Репродуктивне здоров'я жінки, 60-65 , 2025 2025 Citations: 1
ПОРІВНЯЛЬНИЙ АНАЛІЗ ЕФЕКТИВНОСТІ ЛАПАРОСКОПІЧНОГО ОРГАНОЗБЕРІГАЮЧОГО ЛІКУВАННЯ ГЛИБОКОГО ЕНДОМЕТРІОЗУ ЗА СТАНДАРТИЗОВАНОЮ МЕТОДИКОЮ ТА КЛАСИЧНИМ МЕТОДОМ ХД Гайдаржі, ГЛ Лавриненко, ІЗ Гладчук Одеський медичний журнал, 60-65 , 2025 2025
Проліферативні зміни у молочних залозах у хворих із зовнішнім генітальним ендометріозом АС Лунько, ІЗ Гладчук, АГ Волянська 2025
Ефективність нутритивної корекції дефіциту заліза у хворих на генітальний ендометріоз, що супроводжується анемією легкого ступеня ІЗ Гладчук, АГ Волянська, АС Лунько, ТА Лунько 2025
Запальні захворювання жіночих статевих органів: методичні рекомендації ІЗ Гладчук, НМ Рожковська, ІВ Антоненко 2025
Підготовка лікарів-інтернів за спеціальністю «Акушерство і гінекологія»: методичні рекомендації для керівників баз стажування АГ Волянська, ІЗ Гладчук, ВП Міщенко 2025
Внутрішньочеревні кровотечі в гінекології: монографія ІЗ Гладчук, ОЯ Назаренко, РО Ткаченко 2025 Citations: 8
Кольпопоез у дівчат з синдромом Маєра-Рокітанського-Кюстнера-Гаузера КП Літвін, ІЗ Гладчук, ГВ Шитова 2024
Стандартизація органозберігаючого лапароскопічного лікування жінок із больовим синдромом, асоційованим із глибоким ендометріозом ХД Гайдаржі, ІЗ Гладчук 2024 Citations: 2
Новаторські підходи до використання ультразвукової діагностики на кафедрі акушерства і гінекології: освітні шляхи для здобувачів OHMeдУ ІЗ Гладчук, ЮВ Онищенко 2024
Порівняльний аналіз частоти післяопераційних внутрішньоматкових синехій при класичному способі гістероскопічної метропластики та модифікованому методі ЮЛ Каліцинська, ІЗ Гладчук, ДО Григурко 2024
Інноваційні підходи до використання ультразвукової діагностики в навчальному процесі здобувачів ОНМедУ на кафедрі акушерства та гінекології ІЗ Гладчук, ЮВ Онищенко 2024
Зміни біохімічних маркерів платинорезистентності під впливом гіпертермії під час процедури hipec при епітеліальному раку яєчників МС Четверіков, ІЗ Гладчук 2024
Репродуктивне здоровя жінок в умовах війни в Україні ІЗ Гладчук, ГП Тарновська МОРСЬКОЇ МЕДИЦИНИ, 158 , 2024 2024
Методика ICG-маркування у сучасній тазовій хірургії: прикладні аспекти (Огляд літератури) ІЗ Гладчук, ДА Кір’якова, ОЄ Сідак, ВЛ Кожаков 2024 Citations: 1
Інтра-та ранні післяопераційні результати при виконанні біопсії сигнальних лімфатичних вузлів під контролем icg маркування у хворих на рак ендометрія початкових стадій ІЗ Гладчук, НМ Рожковська, ВЛ Кожаков, ДА Кір’якова Збірник наукових праць Асоціації акушерів-гінекологів України, 11-16 , 2023 2023
MOST CITED SCHOLAR PUBLICATIONS
Національний консенсус щодо ведення пацієнток із ендометріозом ВМ Запорожан, ТФ Татарчук, ВВ Камінський Репродуктивна ендокринологія, 7-12 , 2015 2015 Citations: 28
Апоплексія яєчника в сучасній гінекології ІЗ Гладчук, ВЛ Кожаков, ОВ Якименко Репродуктивное здоровье женщины, 24 , 2005 2005 Citations: 16
Репродуктивні наслідки у жінок, які перенесли консервативну міомектомію ІЗ Гладчук, ОЯ Назаренко Репродуктивное здоровье женщины 3 (23), 104-106 , 2005 2005 Citations: 11
Внутрішньочеревні кровотечі в гінекології: монографія ІЗ Гладчук, ОЯ Назаренко, РО Ткаченко 2025 Citations: 8
Особливості жовтого тіла при апоплексії яєчника з мінімальною та помірною внутрішньочеревною кровотечею ОВ Ситнікова, ОЯ Назаренко, ІЗ Гладчук, ТО Ліщиновська Буковинський медичний вісник 1, 131-4 , 2019 2019 Citations: 8
Метаболічна терапія у жінок з плацентарною дисфункцією ІЗ Гладчук, ЕА Панчук Збірник наукових праць Асоціації акушерів-гінекологів України, 58-63 , 2018 2018 Citations: 8
Сучасні діагностичні та лікувальні підходи при апоплексії яєчників. Ч. 2 ІЗ Гладчук, АГ Волянська, ОЯ Назаренко, ИЗ Гладчук, АГ Волянская 2015 Citations: 6
Оперативна лапароскопія в лікуванні безплідних хворих з ендометріозом/І. 3. Гладчук, АГ Волянська, СМ Непорада ІЗ Гладчук Вісн. морської медицини, 33-36 , 2010 2010 Citations: 6
Порівняльний аналіз ефективності ендоскопічної та «відкритої» хірургії в комплексному лікуванні тубооваріальних абсцесів ВМ Запорожан, ІЗ Гладчук, ЛА Товштейн Педіатрія, акушерство та гінекологія, 100-102 , 2009 2009 Citations: 6
Мінімальноінвазивна ендоскопічна хірургія у комплексному лікуванні тубооваріальних абсцесів ВМ Запорожан, ІЗ Гладчук, ЛА Товштейн Укр. журн. малоінваз. та ендоскоп. хірургії 4 (1), 44-47 , 2000 2000 Citations: 6
Сучасна концепція надання допомоги жінкам з апоплексією яєчника ІЗ Гладчук, ОЯ Назаренко, КМ Шпрайдун 2021 Citations: 5
Стандартизація лапароскопічного лікування хворих з глибоким інфільтративним ендометріозом ВМ Запорожан, ІЗ Гладчук, НМ Рожковська, ВГ Маричереда, ... 2020 Citations: 5
Особливості прогестерон-синтетичних і апоптотичних процесів у структурних елементах жовтого тіла при апоплексії яєчника ІЗ Гладчук, ОЯ Назаренко ОНМедУ , 2017 2017 Citations: 5
Порівняльний аналіз ефективності методів лікування жінок із синдромом полікістозних яєчників та гіперпролактинемією: ретроспективне дослідження ІЗ Гладчук, ОМ Семенюта, ЮВ Онищенко Здоровье женщины, 121-123 , 2014 2014 Citations: 5
Сучасні хірургічні технології в лікуванні міоми матки (огляд літератури і власні дані) ІЗ Гладчук, НМ Рожковська, ТВ Косей, ИЗ Гладчук, НН Рожковская Збірник наукових праць асоціації акушерів і гінекологів України 2 (38), 123-9 , 2016 2016 Citations: 4
Нові технології у хірургічному лікуванні глибокого інфільтративного і поверхневого перитонеального ендометріозу ВМ Запорожан, ІЗ Гладчук, НМ Рожковська, ВЛ Кожаков, АГ Волянська, ... 2014 Citations: 4
New technologies in surgical treatment of deep infiltrative and superficial peritoneal endometriosis VM Zaporozhan, IZ Gladchuk, NM Rozhkovska, AG Volyanska, ... Reproduktivnaya endokrinologiya 2 (16), 7-9 , 2014 2014 Citations: 4
Оперативна ендоскопія в комплексному лікуванні жіночої безплідності ІЗ Гладчук ступеня канд.. мед. наук: спец. 14.01. 01 «Акушерство і гінекологія»/ІЗ … , 1999 1999 Citations: 4
Часові критерії безпечності виконання гістерорезектоскопічної міомектомії при одиночній субмукозній міомі матки ІЗ Гладчук, ЮО Чеханов, КВ Латій Здобутки клінічної i експериментальної медицини, 45-50 , 2017 2017 Citations: 3
INDUSTRY EXPERIENCE
35 years as ObGyn specialist
30 years in science of ObGyn speciality
SOCIAL, ECONOMIC, or ACADEMIC BENEFITS
In 2009 was awarded the Order of Merit, III degree
